Next Article in Journal
The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence
Previous Article in Journal
Contrasting Effects of Larval Escitalopram and Serotonin-Synthesis Inhibitor on Adult Phototaxis in Drosophila w1118
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Long-Term Study of the Changes in Symptoms and Signs of Dry Eye Disease in Participants Non-Adherent to Treatment

by
Belen Sabucedo-Villamarin
1,
Jacobo Garcia-Queiruga
1,2,*,
Hugo Pena-Verdeal
1,2,*,
María José Ginzo-Villamayor
3,
Carlos Garcia-Resua
1,2,
Maria J. Giraldez
1,2 and
Eva Yebra-Pimentel
1,2
1
GI-2092-Optometry, Departamento de Física Aplicada (Área de Optometría), Universidade de Santiago de Compostela, Campus Vida s/n, 15701 Santiago de Compostela, Galicia, Spain
2
AC-24-Optometry, Instituto de Investigación Sanitaria (IDIS), Travesía da Choupana S/N, 15706 Santiago de Compostela, Galicia, Spain
3
GI-1914-MODESTYA, Departamento de Estadística, Análisis Matemático y Optimización, Universidade de Santiago de Compostela, Campus Vida s/n, 15782 Santiago de Compostela, Galicia, Spain
*
Authors to whom correspondence should be addressed.
Life 2025, 15(11), 1783; https://doi.org/10.3390/life15111783
Submission received: 21 October 2025 / Revised: 12 November 2025 / Accepted: 17 November 2025 / Published: 20 November 2025
(This article belongs to the Section Physiology and Pathology)

Abstract

Background: The purpose of this study was to assess differences in clinical symptoms and signs of DED in non-adherent to treatment patients to describe long-term disease progression. Methods: 120 patients previously diagnosed with Dry Eye Disease (DED) were contacted to undergo a second eye examination. The final included participants were classified into three groups based on when the second examination was scheduled: 4 years (Group 1; n = 33), 6 years (Group 2; n = 18) or 8 years (Group 3; n = 37) since the diagnostic visit. All included participants were classified as ‘non-adherent to DED treatment’, defined as patients who reported not following their prescribed DED therapy. In both examinations, Ocular Surface Disease Index (OSDI) questionnaire, tear film osmolarity, inter-eye osmolarity (osmolarity|OD-OS|), Fluorescein Break-Up Time (FBUT), Maximum Blink Interval (MBI) and corneal staining were evaluated. Results: OSDI score improved after 4 years of DED diagnosis (Group 1, mean difference close to 12 points, p < 0.001) and after 8 years (Group 3, mean difference of 9 points, p < 0.001), but remained stable after 6 years (Group 2, p = 0.328). Osmolarity worsened only after 6 years of DED diagnosis (Group 2, mean difference of 13.2 mOsm/L, p = 0.011), while osmolarity|OD–OS| showed no change (all p ≥ 0.231). FBUT values were stable across all groups (all p ≥ 0.265). MBI increased after 4 and 8 years of DED diagnosis (Groups 1 and 3, p ≤ 0.003), but not after 6 years (Group 2, p = 0.391). Corneal staining worsened after 8 years of DED diagnosis (Group 3, 0.55 points, p = 0.011), with no changes at 4 or 6 years (Groups 1 and 2, both p ≥ 0.318). Conclusions: In non-adherent DED patients, osmolarity|OD-OS| and tear film stability remain stable during the natural course of the disease, while ocular surface damage increases. However, the subjective symptomatology and the nociceptive blink reflex due to ocular discomfort decreased since the diagnostic visit.
Keywords: DED natural course; OSDI questionnaire; tear film osmolarity; tear film stability; corneal staining; longitudinal study; maximum blink interval DED natural course; OSDI questionnaire; tear film osmolarity; tear film stability; corneal staining; longitudinal study; maximum blink interval

Share and Cite

MDPI and ACS Style

Sabucedo-Villamarin, B.; Garcia-Queiruga, J.; Pena-Verdeal, H.; Ginzo-Villamayor, M.J.; Garcia-Resua, C.; Giraldez, M.J.; Yebra-Pimentel, E. Long-Term Study of the Changes in Symptoms and Signs of Dry Eye Disease in Participants Non-Adherent to Treatment. Life 2025, 15, 1783. https://doi.org/10.3390/life15111783

AMA Style

Sabucedo-Villamarin B, Garcia-Queiruga J, Pena-Verdeal H, Ginzo-Villamayor MJ, Garcia-Resua C, Giraldez MJ, Yebra-Pimentel E. Long-Term Study of the Changes in Symptoms and Signs of Dry Eye Disease in Participants Non-Adherent to Treatment. Life. 2025; 15(11):1783. https://doi.org/10.3390/life15111783

Chicago/Turabian Style

Sabucedo-Villamarin, Belen, Jacobo Garcia-Queiruga, Hugo Pena-Verdeal, María José Ginzo-Villamayor, Carlos Garcia-Resua, Maria J. Giraldez, and Eva Yebra-Pimentel. 2025. "Long-Term Study of the Changes in Symptoms and Signs of Dry Eye Disease in Participants Non-Adherent to Treatment" Life 15, no. 11: 1783. https://doi.org/10.3390/life15111783

APA Style

Sabucedo-Villamarin, B., Garcia-Queiruga, J., Pena-Verdeal, H., Ginzo-Villamayor, M. J., Garcia-Resua, C., Giraldez, M. J., & Yebra-Pimentel, E. (2025). Long-Term Study of the Changes in Symptoms and Signs of Dry Eye Disease in Participants Non-Adherent to Treatment. Life, 15(11), 1783. https://doi.org/10.3390/life15111783

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop